Most Read Articles
Roshini Claire Anthony, 29 May 2020

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

05 Nov 2019
Low total cholesterol levels appear to carry increased major adverse cardiovascular events (MACE) hazard in older men without ischaemic heart disease (IHD) and not receiving statin therapy but not to those on statins, according to data from the CHAMP (Concord Health and Ageing in Men Project) cohort.
Elvira Manzano, 13 Apr 2020
A gout drug that’s been around for years reduced the risk of ischaemic cardiovascular (CV) events when given at a low dose in patients who had myocardial infarction (MI) and was cost-effective, an analysis of the COLCOT* trial has shown.
27 May 2020
Glycated haemoglobin (HbA1c) levels appear to be an independent predictor of coronary artery disease in patients with ST-elevation myocardial infarction, a new study has found.

Lower SBP tied to reduced risk of CVD in older patients

01 Nov 2019
The impacts of loosened blood pressure guidelines

Blood pressure (BP) that is lower than currently recommended levels does not pose any harm in older patients without previous cardiovascular disease (CVD), according to a study. The association between lower systolic (S)BP and lesser risk of CVD suggests the benefit of having a lower SBP.

Of the 31,704 patients included, 26,663 were aged 40–75 years and 5,041 were 76–90 years. Mean follow-up was 2 years. There were no significant differences in risk of any outcome among younger patients, but an association was found between low BP and the lowest risk of CVD in the older group.

The incidence of CVD was lower in older patients in the 110–129 mm Hg group when compared with the reference group. After adjustment for covariates, older patients in this group had a hazard ratio (HR) for CVD of 0.60 (95 percent CI, 0.40–0.92) as compared with the reference group.

This study sought to compare the risk of CVD—nonfatal acute myocardial infarction (AMI) or stroke—at BP levels that met current recommendations with risk at lower levels, especially in older patients. The authors identified individuals with hypertension aged 40–90 years from a primary care register. Those with a history of cancer, diabetes mellitus or CVD were not included.

Patients were divided into age groups of 40–75 years and 76–90 years and into SBP groups of 110–129, 130–139 (reference), 140–149 and ≥150 mm Hg. The Kaplan-Meier estimator was used to examine the incidence of AMI, stroke and a composite of the two. HRs for outcomes were estimated using Cox proportional hazards regression.

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 29 May 2020

For coffee drinkers, drinking filtered coffee may be tied to a lower mortality risk, including cardiovascular disease (CVD)-related mortality, a study from Norway suggested.

05 Nov 2019
Low total cholesterol levels appear to carry increased major adverse cardiovascular events (MACE) hazard in older men without ischaemic heart disease (IHD) and not receiving statin therapy but not to those on statins, according to data from the CHAMP (Concord Health and Ageing in Men Project) cohort.
Elvira Manzano, 13 Apr 2020
A gout drug that’s been around for years reduced the risk of ischaemic cardiovascular (CV) events when given at a low dose in patients who had myocardial infarction (MI) and was cost-effective, an analysis of the COLCOT* trial has shown.
27 May 2020
Glycated haemoglobin (HbA1c) levels appear to be an independent predictor of coronary artery disease in patients with ST-elevation myocardial infarction, a new study has found.